Global & Public Health (all articles)
CDC to shorten COVID-19 quarantine to 10 days, 7 with test
3 Dec, 2020 | 08:40h | UTCCDC to shorten COVID-19 quarantine to 10 days, 7 with test – Associated Press
Commentary: CDC Shortens Its COVID-19 Quarantine Recommendations – NPR
Special Report: The Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them
3 Dec, 2020 | 08:42h | UTCThe Covid-19 vaccines are a marvel of science. Here’s how we can make the best use of them – STAT
Randomized trial: In areas with intense malaria transmission, postdischarge malaria chemoprevention in children recently treated for severe anemia prevented deaths and readmissions
3 Dec, 2020 | 08:33h | UTCVisual abstract: Malaria Chemoprevention for Management of Severe Anemia
Case series: Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer
2 Dec, 2020 | 07:31h | UTC
What’s the difference between viral shedding and reinfection with COVID-19?
2 Dec, 2020 | 07:29h | UTCWhat’s the difference between viral shedding and reinfection with COVID-19? – The Conversation
Opinion: “Put an end to publication by proclamation for Covid vaccines”
2 Dec, 2020 | 07:27h | UTCPut An End To Publication By Proclamation For Covid Vaccines – Forbes
One in five covid-19 patients are diagnosed with a mental illness within three months
2 Dec, 2020 | 07:24h | UTC
Commentary on Twitter
"Survivors of COVID-19 appear to be at increased risk of psychiatric sequelae, and a psychiatric diagnosis might be an independent risk factor for #COVID-19."
New #Free Researchhttps://t.co/i00uBVdV0O
— The Lancet Psychiatry (@TheLancetPsych) November 10, 2020
CDC panel moves health workers, nursing home residents to front of COVID vaccine line
2 Dec, 2020 | 07:26h | UTCCDC panel moves health workers, nursing home residents to front of COVID vaccine line – CIDRAP
Two meta-analysis find ethnic minorities disproportionately affected by coronavirus
2 Dec, 2020 | 07:22h | UTCMeta-analysis 1: Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths: A Systematic Review – Annals of Internal Medicine
Meta-analysis 2: Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis – EClinicalMedicine
Commentary: Ethnic minorities disproportionately affected by coronavirus, meta-study finds – Reuters
Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019. At least one in every three people in the world needs rehabilitation at some point in the course of their illness or injury
2 Dec, 2020 | 07:17h | UTC
Systematic review: Outdoor transmission of SARS-CoV-2 and other respiratory viruses. “The odds of indoor transmission was very high compared to outdoors (18.7 times)”
2 Dec, 2020 | 07:19h | UTC
Commentary on Twitter
Outdoor Transmission of SARS-CoV-2 and Other Respiratory Viruses, a Systematic Review https://t.co/lmWQNgpIfd Existing evidence supports the wide-held belief that the the risk of #SARSCoV2 transmission is lower outdoors (< 10%).
— Carlos del Rio (@CarlosdelRio7) December 1, 2020
WHO World malaria report 2020: 20 years of global progress & challenges
1 Dec, 2020 | 08:27h | UTCWorld malaria report 2020: 20 years of global progress & challenges – World Health Organization
News Release: WHO calls for reinvigorated action to fight malaria
Moderna released more Covid-19 vaccine results. They’re very encouraging.
1 Dec, 2020 | 08:15h | UTCModerna released more Covid-19 vaccine results. They’re very encouraging. – Vox
Commentaries: ‘Absolutely remarkable’: No one who got Moderna’s vaccine in trial developed severe COVID-19 – Science AND Moderna to submit Covid-19 vaccine to FDA as full results show 94% efficacy – STAT AND More Good News For Moderna’s COVID-19 Vaccine Candidate – NPR AND Moderna to seek emergency authorization for COVID-19 vaccine – CIDRAP
Commentary on Twitter
Moderna has announced the final results of the 30,000-person efficacy trial for its #COVID19 vaccine candidate, reporting that the vaccine had 100% efficacy against severe disease. https://t.co/Cgg0I5nv9r
— News from Science (@NewsfromScience) November 30, 2020
Opinion: Pfizer and Moderna’s “95% effective” vaccines—let’s be cautious and first see the full data
1 Dec, 2020 | 08:13h | UTC
Colchicine to be investigated as a possible treatment for COVID-19 in the RECOVERY trial
1 Dec, 2020 | 08:08h | UTCCommentary: Gout drug Colchicine to be tested as COVID-19 treatment in UK trial – Reuters
Critically ill patients with COVID-19: A narrative review on prone position
1 Dec, 2020 | 08:07h | UTCCritically Ill Patients with COVID-19: A Narrative Review on Prone Position – Pulmonary Therapy
The Ioannidis affair: A tale of major scientific overreaction
1 Dec, 2020 | 08:10h | UTCThe Ioannidis Affair: A Tale of Major Scientific Overreaction – Scientific American
The COVID science wars: Shutting down scientific debate is hurting the public health
1 Dec, 2020 | 08:11h | UTCThe COVID Science Wars – Scientific American
Report: SARS-CoV-2 setting-specific transmission rates. Households showed the highest transmission rates (21.1%). Asymptomatic infections do occur but much less efficiently than symptomatic infection.
30 Nov, 2020 | 01:01h | UTCFull report: SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis – Imperial College London
AstraZeneca vaccine most attractive option for Africa, says WHO – Astra Zeneca CEO says company will run new trial to test more efficient dose
1 Dec, 2020 | 08:05h | UTC
No evidence for increased transmissibility from mutations in SARS-CoV-2
30 Nov, 2020 | 01:06h | UTCCommentaries: Mutations not making coronavirus able to spread more rapidly -study – Reuters AND Covid-19 has NOT become more infectious: Study identifies almost 13,000 coronavirus mutations but none – including the dominant D614G strain – made it better at spreading – Daily Mail
Study: Fewer than 10% of people in the US had detectable SARS-CoV-2 antibodies as of September 2020
30 Nov, 2020 | 01:00h | UTCEstimated SARS-CoV-2 Seroprevalence in the US as of September 2020 – JAMA Internal Medicine
Commentaries: Less than 10% of Americans had COVID by September, study finds – CIDRAP AND Antibodies, Immunity, and COVID-19 – JAMA Internal Medicine AND Covid-19: Nationwide SARS-CoV-2 Seroprevalence Remains Low – Physician’s Weekly
Commentary on Twitter
.@CDCgov tested more than 177,000 serum samples across 52 sites (50 states, DC, and Puerto Rico) between July 27 and September 24 for #SARSCoV2 antibodies. The study found that, in 45 US sites, less than 10% of samples had evidence of previous infection https://t.co/U4hp68fFAx
— JAMA Internal Medicine (@JAMAInternalMed) November 24, 2020
Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany estimated at 0.36%
30 Nov, 2020 | 01:02h | UTCInfection fatality rate of SARS-CoV2 in a super-spreading event in Germany – Nature Communications
Seroprevalence meta-analysis predicts 643 million already infected by SARS-CoV-2 globally
30 Nov, 2020 | 00:59h | UTCOriginal study: Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis – medRxiv
Opinion – Covid-19: controversial trial may actually show that masks protect the wearer
30 Nov, 2020 | 00:58h | UTCCovid-19: controversial trial may actually show that masks protect the wearer – The BMJ Opinion
Original study and commentaries: Randomized trial suggesting mask use does not protect the wearer from Covid-19 sparks controversy
Related commentary on Twitter (thread – click for more)
1/
My appraisal of the Danish mask study (DANMASK-19): This was a negative trial – masks were not shown to prevent #COVID19.Could chance or bias make this outcome more likely?
Does this mean we don’t need to wear masks?Let’s take a deeper look.#HowIReadThisPaper
(Thread) pic.twitter.com/bAUuajgtaI
— Rahul Ganatra (@rbganatra) November 28, 2020